Slate Path Capital LP - 31 Dec 2024 SCHEDULE 13G/A Report for Cue Biopharma, Inc. Common stock, par value $0.001 per share (CUE)

Filing Manager
Slate Path Capital LP
Reporting Manager
Slate Path Capital LP
Security
Cue Biopharma, Inc. Common stock, par value $0.001 per share
Symbol
CUE
Shares outstanding
65,631,143 shares
Disclosed Ownership
918,836 shares
Ownership
1.4%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 17:00:20 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Slate Path Capital LP 1.4% 918,836 0 918,836 /s/ John Metzner By: Jades GP, LLC, General Partner, By: John Metzner, Chief Operating Officer
David Greenspan 1.4% 918,836 0 918,836 /s/ Jim Feeney Jim Feeney, Attorney-In-Fact*